These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 37676606)

  • 1. Artificial Intelligence in ADME Property Prediction.
    Siramshetty VB; Xu X; Shah P
    Methods Mol Biol; 2024; 2714():307-327. PubMed ID: 37676606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology.
    Hudson IL
    Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.
    Chou WC; Lin Z
    Toxicol Sci; 2023 Jan; 191(1):1-14. PubMed ID: 36156156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress of Deep Learning in Drug Discovery.
    Wang F; Diao X; Chang S; Xu L
    Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Trends and Future Prospective of In Silico Models from the Viewpoint of ADME Evaluation in Drug Discovery.
    Komura H; Watanabe R; Mizuguchi K
    Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets.
    Wenzel J; Matter H; Schmidt F
    J Chem Inf Model; 2019 Mar; 59(3):1253-1268. PubMed ID: 30615828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
    Yang X; Wang Y; Byrne R; Schneider G; Yang S
    Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in de Novo Drug Design: From Conventional to Machine Learning Methods.
    Mouchlis VD; Afantitis A; Serra A; Fratello M; Papadiamantis AG; Aidinis V; Lynch I; Greco D; Melagraki G
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying machine learning techniques for ADME-Tox prediction: a review.
    Maltarollo VG; Gertrudes JC; Oliveira PR; Honorio KM
    Expert Opin Drug Metab Toxicol; 2015 Feb; 11(2):259-71. PubMed ID: 25440524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Deep Learning With Multiple Machine Learning Methods and Metrics Using Diverse Drug Discovery Data Sets.
    Korotcov A; Tkachenko V; Russo DP; Ekins S
    Mol Pharm; 2017 Dec; 14(12):4462-4475. PubMed ID: 29096442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemi-Net: A Molecular Graph Convolutional Network for Accurate Drug Property Prediction.
    Liu K; Sun X; Jia L; Ma J; Xing H; Wu J; Gao H; Sun Y; Boulnois F; Fan J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FP-GNN: a versatile deep learning architecture for enhanced molecular property prediction.
    Cai H; Zhang H; Zhao D; Wu J; Wang L
    Brief Bioinform; 2022 Nov; 23(6):. PubMed ID: 36124766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Digital Pharmaceutical Sciences.
    Damiati SA
    AAPS PharmSciTech; 2020 Jul; 21(6):206. PubMed ID: 32715351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
    Sahu A; Mishra J; Kushwaha N
    Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Next Era: Deep Learning in Pharmaceutical Research.
    Ekins S
    Pharm Res; 2016 Nov; 33(11):2594-603. PubMed ID: 27599991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Systematic Review of Deep Learning Methodologies Used in the Drug Discovery Process with Emphasis on In Vivo Validation.
    Koutroumpa NM; Papavasileiou KD; Papadiamantis AG; Melagraki G; Afantitis A
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Artificial Intelligence in Drug Design.
    Hessler G; Baringhaus KH
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30279331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep Learning for Drug Design: an Artificial Intelligence Paradigm for Drug Discovery in the Big Data Era.
    Jing Y; Bian Y; Hu Z; Wang L; Xie XQ
    AAPS J; 2018 Mar; 20(3):58. PubMed ID: 29603063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.